CD Biosynsis offers integrated Vibrio natriegens Metabolic Pathway Optimization Services, designed to maximize the yield and productivity of target compounds in this ultra-fast-growing host. V. natriegens is the ideal chassis for high-speed biomanufacturing due to its rapid growth rate (approximately 10 min doubling time) and high biomass accumulation. Our optimization services move beyond single gene edits, utilizing a systematic approach that combines Constraint-Based Metabolic Modeling (CBM), high-precision gene editing (e.g., CRISPR-Cas9 and Base Editing), and tunable gene regulation (CRISPRi). This integrated strategy allows for the rapid identification and removal of metabolic bottlenecks, precise tuning of expression levels, and efficient redirection of carbon flux, ensuring the industrial viability of complex engineered pathways within the V. natriegens dual-chromosome system.
Get a QuoteOptimizing a metabolic pathway in V. natriegens requires managing the rapid consumption of substrate and the complex flux dynamics across its native dual-chromosome system. Our platform employs the Design-Build-Test-Learn (DBTL) cycle, where computational modeling (Design) guides the construction of engineered strains (Build). Phenotypic testing (Test) and data analysis (Learn) inform the next round of rational modifications. This systematic, data-driven methodology eliminates reliance on trial-and-error, allowing us to rapidly achieve high product titers, especially for pathways involving multiple heterologous genes and competing native pathways.
Constraint-Based Modeling (CBM)
Utilization of the V. natriegens genome-scale model to predict maximum theoretical yields and identify optimal gene knockouts for flux redirection to the target product.
Metabolomics & Fluxomics
Experimental measurement of intracellular metabolite levels and metabolic fluxes (via 13C tracing) to pinpoint rate-limiting enzymatic steps (bottlenecks) in the pathway.
Optimal Promoter Prediction
In-silico prediction of required enzyme expression levels for pathway balancing, guiding the selection of synthetic promoter strengths and Ribosome Binding Site (RBS) tuning.
CRISPR-Cas9 Editing
High-efficiency permanent gene knockouts or large genomic insertions/deletions for eliminating competing pathways and introducing heterologous enzymes.
Base Editing (BE)
Precision single-nucleotide substitutions (C>T, A>G) for fine-tuning promoter/RBS strength or optimizing enzyme kcat without introducing DNA breaks or indels.
CRISPR Interference (CRISPRi)
Tunable and reversible gene knockdown (partial repression) used for balancing flux through essential or highly sensitive native pathways.
Modular Pathway Assembly
Dividing long pathways into functional modules for co-localization or sequential expression, reducing metabolic burden and improving intermediate channeling.
Genome Integration
Stable chromosomal integration of heterologous pathways onto V. natriegens's Chr I or Chr II to ensure genetic stability during high-speed, long-term fermentation.
High-Throughput Library Screening
Utilization of automated platforms and promoter libraries to rapidly screen hundreds of pathway variants for the optimal combination of expression levels.
A systematic process for rational pathway design and optimization.
1. Design (Modeling & Analysis)
2. Build (Gene Editing)
3. Test (Assay & Phenotype)
4. Learn (Data Integration)
Establish the target pathway and perform CBM to predict flux targets (knockouts/additions).
Design genetic modifications using predicted optimal expression levels (promoter/RBS tuning).
Select appropriate V. natriegens chromosome integration sites for stability.
Construct gene circuits, operons, and editing tools (CRISPR-Cas9, Base Editor, CRISPRi).
Introduce modifications into the V. natriegens genome via optimized transformation/conjugation protocols.
Generate small-scale, rationally designed strain libraries (e.g., promoter libraries).
Compare experimental results against initial model predictions.
Refine the metabolic model, identify errors, and calculate the next set of rational genetic modifications (e.g., tighter repression, different RBS strength).
Deliver the optimized V. natriegens production strain.
Integrated DBTL Cycle
Combines computational modeling (Design/Learn) with high-precision tools (Build/Test) to ensure every modification is guided by data, significantly reducing R&D iterations.
Precision Regulatory Control
Uses Base Editing for fine-tuning expression levels (RBS/Promoter) and CRISPRi for reversible repression, achieving pathway balancing superior to simple knockouts.
Host-Specific Model
Optimization is based on the V. natriegens genome-scale metabolic model, providing unique insights into the fast-growing, dual-chromosome system not available for standard hosts.
Stable Chromosomal Integration
We prioritize stable pathway integration into either Chromosome I or II, ensuring the pathway remains functional and non-lost during V. natriegens's rapid cell division cycles.
1. What is the primary advantage of V. natriegens for pathway optimization?
The primary advantage is its extremely rapid growth rate (approximately 10 min doubling time). This allows for much faster substrate conversion and product accumulation, leading to higher volumetric productivity in a fermenter compared to E. coli or yeast.
2. How does metabolic modeling guide the optimization process?
Metabolic modeling (CBM) predicts the theoretical maximum product yield and identifies the key genetic interventions (like gene knockouts or flux boosts) required to achieve that maximum, allowing us to rationally prioritize engineering targets before costly lab work begins.
3. Can you optimize a pathway that uses genes from a non-native species?
Yes. We specialize in engineering heterologous pathways by synthesizing and optimizing foreign genes for expression in V. natriegens, ensuring codon optimization and balancing the expression levels of the foreign enzymes with the host's native machinery.
4. Why use Base Editing and CRISPRi instead of just CRISPR-Cas9 knockouts?
Simple knockouts often lead to flux imbalances. Base Editing and CRISPRi offer fine, tunable control (partial repression or slight expression changes), which is crucial for achieving optimal stoichiometry and balancing pathway flux, leading to higher final titers.
5. How is the pathway stabilized in the V. natriegens genome?
We prioritize stable chromosomal integration into non-essential 'safe harbor' sites on Chromosome I or II. This prevents pathway loss, which is a significant risk when using plasmids in a cell with a 10-minute doubling time.
6. Does the dual-chromosome system complicate the engineering?
Yes, it adds complexity, as key metabolic genes are distributed across both chromosomes. Our custom tools and modeling services are specifically designed to address this challenge, ensuring successful editing and stable integration on both chromosomes.
7. What is included in the 'Learn' phase of the DBTL cycle?
The 'Learn' phase involves integrating all experimental data (e.g., product titers, fluxomics) back into the computational model. This step identifies discrepancies, refines our understanding of the V. natriegens metabolism, and generates the next set of rational design rules.
8. What output data is provided upon completion of the service?
We deliver the optimized V. natriegens strain, all final sequences, and a detailed report including product titer and yield data, metabolic flux analysis (if requested), and the final predictive metabolic model used for the optimization.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.